We are live on !
Find out more
Jim Simons Renaissance Technologies
AUM
$72.6B
Turnover
31.08%
1-Year Est. Return
54.88%
Jim Simons is the founder of Renaissance Technologies, one of the most successful quantitative hedge funds in the world. Before his career in finance, he served as a mathematics professor and made significant contributions to differential geometry. Simons applied his analytical expertise to develop sophisticated, algorithm-driven trading strategies, earning consistently high returns for investors.
This Fund
S&P 500
This Quarter Est. Return
+9.03%
1 Year Est. Return
+54.88%
3 Year Est. Return
+169.34%
5 Year Est. Return
+186.18%
10 Year Est. Return
+887.92%
AUM
$41.8B
AUM Growth
+$537M
(+1.3%)
Cap. Flow
-$2.31B
Cap. Flow % of AUM
Cap. Flow %
-5.54%
Top 10 Holdings %
Top 10 Hldgs %
11.46%
Holding
3,281
New
498
Increased
1,316
Reduced
982
Closed
464
Avg Time Held
0.4
years
Top 10 Avg Time Held
0.4
years
Top 20 Avg Time Held
0.4
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pfizer
PFE
|
+$230M |
| 2 |
Johnson & Johnson
JNJ
|
+$205M |
| 3 |
Bank of America
BAC
|
+$163M |
| 4 |
Costco
COST
|
+$162M |
| 5 |
GSK
GSK
|
+$131M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
IBM
IBM
|
+$396M |
| 2 |
Bristol-Myers Squibb
BMY
|
+$219M |
| 3 |
GE Aerospace
GE
|
+$156M |
| 4 |
Walt Disney
DIS
|
+$154M |
| 5 |
Amazon
AMZN
|
+$138M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 15.2% |
| 2 | Healthcare | 13.65% |
| 3 | Consumer Discretionary | 12.36% |
| 4 | Consumer Staples | 11.26% |
| 5 | Industrials | 10.71% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
1
McDonald's
MCD
$200B
| $735M | 1.76% |
7,570,700
+108,300
| +1% | +$10.4M |
2013 Q2
2 quarters
|
|
2
Novo Nordisk
NVO
$179B
| $603M | 1.44% |
32,637,000
+1,275,000
| +4% | +$22.2M |
2013 Q2
2 quarters
|
|
3
TSMC
TSM
$2.02T
| $507M | 1.21% |
29,058,671
+6,256,320
| +27% | +$111M |
2013 Q2
2 quarters
|
|
|
4
Johnson & Johnson
JNJ
$678B
| $504M | 1.21% |
5,498,400
+2,223,100
| +68% | +$205M |
2013 Q2
2 quarters
|
|
|
LLTC
5
DELISTED
Linear Technology Corp
LLTC
| $495M | 1.19% |
10,877,500
+165,200
| +2% | +$6.89M |
2013 Q2
2 quarters
|
|
6
Colgate-Palmolive
CL
$78.4B
| $479M | 1.15% |
7,348,400
-317,100
| -4% | -$20.3M |
2013 Q2
2 quarters
|
|
7
Hershey
HSY
$34.6B
| $421M | 1.01% |
4,334,000
-304,600
| -7% | -$29.3M |
2013 Q2
2 quarters
|
|
8
Eli Lilly
LLY
$1.27T
| $360M | 0.86% |
7,061,700
-1,226,105
| -15% | -$61.4M |
2013 Q2
2 quarters
|
|
|
9
GSK
GSK
$103B
| $343M | 0.82% |
5,140,000
+2,026,960
| +65% | +$131M |
2013 Q2
2 quarters
|
|
|
10
Costco
COST
$473B
| $340M | 0.81% |
2,857,513
+1,355,800
| +90% | +$162M |
2013 Q2
2 quarters
|
|
11
Alaska Air
ALK
$4.68B
| $338M | 0.81% |
9,201,600
+663,400
| +8% | +$23.6M |
2013 Q2
2 quarters
|
|
12
Intel
INTC
$304B
| $295M | 0.71% |
11,370,700
-926,294
| -8% | -$22.4M |
2013 Q2
2 quarters
|
|
|
WFM
13
DELISTED
Whole Foods Market Inc
WFM
| $287M | 0.69% |
4,954,600
-569,648
| -10% | -$33.8M |
2013 Q2
2 quarters
|
|
14
Verizon
VZ
$192B
| $285M | 0.68% |
5,802,317
+593,000
| +11% | +$29.2M |
2013 Q2
2 quarters
|
|
15
VeriSign
VRSN
$27.7B
| $277M | 0.66% |
4,625,776
-446,800
| -9% | -$24.6M |
2013 Q2
2 quarters
|
|
16
Walmart Inc
WMT
$1T
| $267M | 0.64% |
10,191,000
-1,176,300
| -10% | -$30.4M |
2013 Q2
2 quarters
|
|
17
TJX Companies
TJX
$151B
| $265M | 0.63% |
8,303,800
-1,723,800
| -17% | -$52.2M |
2013 Q2
2 quarters
|
|
18
Philip Morris
PM
$303B
| $259M | 0.62% |
2,977,700
-587,800
| -16% | -$51.3M |
2013 Q2
2 quarters
|
|
|
TWTC
19
DELISTED
TW TELECOM INC CL A COM
TWTC
| $258M | 0.62% |
8,466,200
+1,138,000
| +16% | +$33.9M |
2013 Q2
2 quarters
|
|
20
NetEase
NTES
$82B
| $250M | 0.6% |
15,912,000
-2,101,500
| -12% | -$29.5M |
2013 Q2
2 quarters
|
|
21
Home Depot
HD
$351B
| $246M | 0.59% |
2,989,900
-201,300
| -6% | -$15.7M |
2013 Q2
2 quarters
|
|
22
DELISTED
LIFE TECHNOLOGIES CORP COM STK (DE)
LIFE
| $246M | 0.59% |
3,241,897
+1,384,000
| +74% | +$104M |
2013 Q2
2 quarters
|
|
|
CELG
23
DELISTED
Celgene Corp
CELG
| $237M | 0.57% |
2,810,938
-524,262
| -16% | -$41.5M |
2013 Q2
2 quarters
|
|
|
24
Pfizer
PFE
$167B
| $230M | 0.55% |
+7,904,832
| New | +$230M |
2013 Q4
0 quarters
|
|
25
Qualcomm
QCOM
$182B
| $217M | 0.52% |
2,916,560
-291,200
| -9% | -$20.5M |
2013 Q2
2 quarters
|
|
Similar funds
Jim Simons's Q4 2013 Portfolio in Review
As of Q4 2013, Jim Simons held 3,281 positions worth $41.8B, up 1.3% from $41.2B the previous quarter. Its ten largest holdings account for 11% of the portfolio.
Jim Simons withdrew a net $2.31B in Q4 2013, closing 464 positions and reducing 982 holdings. Its most notable exit was GE Aerospace, an estimated $156M position sold in full.
By sector, the portfolio is most concentrated in Technology at 15% of assets, up from 15% a quarter earlier, followed by Healthcare and Consumer Discretionary.
Against the trend, Jim Simons opened a new position in Pfizer worth $230M.
- Jim Simons's largest Q4 2013 buy was Pfizer: 7,904,832 shares worth $230M.
- Jim Simons added most to Johnson & Johnson in Q4 2013, an estimated $205M increase.
- Jim Simons's biggest Q4 2013 reduction was IBM, cutting an estimated $396M.
- Jim Simons fully exited GE Aerospace in Q4 2013, selling an estimated $156M.
- Jim Simons's ten largest holdings make up 11% of its $41.8B portfolio in Q4 2013.
- Jim Simons opened 498 new positions and closed 464 in Q4 2013.
- Jim Simons's portfolio value rose 1.3% quarter-over-quarter to $41.8B.
Based on Renaissance Technologies's 13F filing for Q4 2013, filed 14 Feb 2014.